Alexa McGraw
Family Medicine · Wichita, KSNPI 1639884612
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations.
Across 84 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$286
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$219
- Otsuka America Pharmaceutical, Inc.$145
- Amgen$124
- AstraZeneca$119
- Lilly USA, LLC$91
- plus $649 from 16 others
What the payments were for
- Food & beverage$1,634100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $286 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $219 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| Amgen | 7 | $124 |
| AstraZeneca | 7 | $119 |
| Lilly USA, LLC | 5 | $91 |
| AbbVie | 5 | $86 |
| Organon | 1 | $78 |
| Idorsia Pharmaceuticals US Inc | 4 | $64 |
| Merck | 4 | $60 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Novo Nordisk | 3 | $56 |
| Astellas Pharma US Inc | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Boehringer Ingelheim | 2 | $33 |
| Dexcom, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| GSK | 1 | $18 |
| Insulet Corporation | 1 | $18 |
| Bayer | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIFAXAN$110
How this compares
$1,634 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $323 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $141 |
| Atorvastatin Calcium | 11 | $92 |
| Famotidine | 14 | $69 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $28 |
| Prednisone | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.